Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,464
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 1,801–1,850 of 2,017 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00005837	Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer	completed	Phase 2	—	Gynecologic Oncology GroupNETWORK	2	Jun 21, 2013	clinicaltrials
NCT00005999	Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer	completed	Phase 2	—	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 21, 2013	clinicaltrials